← Back to directory
MS
Main Sequence Ventures
Sydney, AustraliaWebsite ↗
Main Sequence Ventures is an Australian deep-tech venture capital firm, established by the national science agency CSIRO, focused on commercializing research by investing in spinouts, startups, and small to medium enterprises (SMEs) connected to Australia's publicly funded research and development sector. The firm aims to solve major global challenges by translating scientific breakthroughs into new industries.
Last raised
Jul 2023
3y 3mo ago
Latest fund size
$310.5M
Main Sequence Fund 3
AUM
$690M
estimated
Funds raised
Capital this firm has raised, newest first
Main Sequence Fund 3
Jul 2023
$310.5M
CSIRO Innovation Fund 2
Jan 2021 · Fund 2
$227.7M
CSIRO Innovation Fund
Jan 2017 · Fund 1
$165.6M
Recent investments
Companies this firm has funded, newest first
| Company | Round | Amount | Date | Source |
|---|---|---|---|---|
| Arkeus | Series A | $18M | May 2026 | thesaasnews.com ↗ |
| AigentsphereLead | Seed | $4M | Apr 2026 | startupdaily.net ↗ |
| DeteqtLead | Seed | $3.5M | Apr 2026 | forbes.com.au ↗ |
| Advanced Navigation | Series C | $110M | Mar 2026 | clay.global ↗ |
| Gilmour Space | Growth | $149.7M | Jan 2026 | afr.com ↗ |
| The EVERY Company | Growth | $55M | Nov 2025 | vcnewsdaily.com ↗ |
| Diraq | Series A | $22M | Jun 2024 | diraq.com ↗ |
| QuintessenceLabsLead | Series B | $17.3M | Oct 2021 | securityweek.com ↗ |
Sources
Where this data came from